2010-01 | A bioassay for mosquito repellency against Aedes aegypti: method validation and bioactivities of DEET analogues | 용철순; 김정선[김정선]; 김석용[김석용]; 김준호[김준호]; 김대덕[김대덕]; 안영준[안영준]; 얀 알렉산더[얀 알렉산더] |
2014-11 | A novel solid dispersion system for natural product-loaded medicine: silymarin-loaded solid dispersion with enhanced oral bioavailability and hepatoprotective activity | 김종오; 황두형; 김용일; 조관형[조관형]; 포우델비자이; 최주연; 김동욱[김동욱]; 신영준[신영준]; 배옥남[배옥남]; 아비드[아비드]; 최한곤[최한곤]; 용철순 |
2013-01 | A novel surface-attached carvedilol solid dispersion with enhanced solubility and dissolution | 용철순; 이성능; 포우델비자이; 트란탄힙; 마라시니니르말; 로샨프라단; 이영임; 이동원; 우종수[우종수]; 최한곤[최한곤]; 김종오 |
2014-07 | Amniotic membrane extract-loaded double-layered wound dressing: evaluation of gel properties and wound healing | 용철순; 최영근; Fakhar ud Din[Fakhar ud Din]; 김동욱[김동욱]; 김용일[김용일]; 김종오; 구세광[구세광]; 나정찬[나정찬]; 허재욱[허재욱]; 이재익[이재익]; 손동환[손동환]; 최한곤[최한곤] |
2011-01 | Antitumor efficacy of solid dispersion of paclitaxel prepared by supercritical antisolvent process in human mammary tumor xenografts | 용철순; 최한곤[최한곤]; 지상철[지상철]; 스리니바산 샨무간[스리니바산 샨무간]; 박재현[박재현]; 우종수[우종수] |
2014-02 | Application of Box-Behnken design in the preparation and optimization of fenofibrate-loaded self-microemulsifying drug delivery system (SMEDDS) | 김종오; 이동원; 마라시니니르말; 포우델비자이; 김정환; 조혁준; 문보경; 최한곤[최한곤]; 용철순 |
2011-04 | Biostable Poly(ethylene oxide)-b-poly(methacrylic acid) Micelles forpH-triggered Release of Doxorubicin | 김종오; 용철순; 최한곤[최한곤]; 최영근; 이동원; 타티아나 브로니치[타티아나 브로니치] |
2015-04 | Characterization of Physicochemical Properties of Spray-dried Solid Dispersions Loaded with Unmodified Crystalline Fenofibrate | 용철순; Abid Mehmood Yousaf[Abid Mehmood Yousaf]; 김동욱[김동욱]; 김종오; 장판식[장판식]; 백형희[백형희]; 임수정[임수정]; 조관형[조관형]; 최한곤[최한곤] |
2014-05 | Chitosan-Based Polyelectrolyte Complexes as Potential Nanoparticulate Carriers: Physicochemical and Biological Characterization | 김종오; 용철순; 티르거네쉬라마사미; 트란탄힙; 조혁준; 김정환; 김용일; 전재윤[전재윤]; 최한곤[최한곤] |
2015-07 | Clopidogrel Napadisilate Monohydrate Loaded Surface-Modified Solid Dispersion: Physicochemical Characterization and in Vivo Evaluation | 김종오; 김영훈[김영훈]; 김동욱[김동욱]; 권민석[권민석]; 조관형[조관형]; 용철순; 최한곤[최한곤] |
2015-09 | Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe | 김종오; 레마나라시드[레마나라시드]; 김동욱[김동욱]; 아비드[아비드]; 오메르[오메르]; 박종혁[박종혁]; 용철순; 오유경[오유경]; 윤유석[윤유석]; 최한곤[최한곤]; 파카르[파카르] |
2014-12 | Comparison of a solid SMEDDS and solid dispersion for enhanced stability and bioavailability of clopidogrel napadisilate | 김종오; 김동욱[김동욱]; 권민석[권민석]; 아비드유사프[아비드유사프]; 프라바가[프라바가]; 박종혁[박종혁]; 김동식[김동식]; 이범진[이범진]; 박영준[박영준]; 최한곤[최한곤]; 용철순 |
2011-11 | Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier | 용철순; 오동훈[오동훈]; 강준혁[강준혁]; 김동욱[김동욱]; 이범진[이범진]; 김종오; 최한곤[최한곤] |
2011-03 | Comparison of the Solubility and Pharmacokinetics of Sildenafil Salts | 용철순; 정시영[정시영]; 서윤기[서윤기]; 김건국[김건국]; 우종수[우종수]; 최한곤[최한곤] |
2013-07 | Cross-linked polymeric micelles based on block ionomer complexes | 김종오; 티르거네쉬라마사미; 용철순; N Nukolova[N Nukolova]; TK Bronich[TK Bronich]; AV Kabanov[AV Kabanov] |
2013-03 | Design and In Vitro Evaluation of Finasteride-Loaded Liquid Crystalline Nanoparticles for Topical Delivery | 김종오; 티아가라쟌; 렌가르잔; 라즈쿠마르타파; 류정연; 최혜윤; 유봉규[유봉규]; 용철순 |
2012-12 | Development and optimization of self-nanoemulsifying drug delivery system with enhanced bioavailability by Box-Behnken design and desirability function | 김종오; 용철순; 마라시니니르말; 엄의동; 포우델비자이; 최한곤[최한곤] |
2010-10 | Development of a novel combination tablet containing trimebutine maleate and mosapride citrate for the treatment of functional dyspepsia | 용철순; 조관형[조관형]; 최영근[최영근]; 강준혁[강준혁]; 최한곤[최한곤]; 박영준[박영준] |
2015-05 | Development of a novel solid lipid nanoparticles-loaded dual-reverse thermosensitive nanomicelle for intramuscular administration with sustained release and reduced toxicity | 용철순; Fakhar ud Din[Fakhar ud Din]; Rehmana Rashid[Rehmana Rashid]; Omer Mustapha[Omer Mustapha]; 김동욱[김동욱]; 박종혁[박종혁]; 구세광[구세광]; 오유경[오유경]; 윤유석[윤유석]; 김종오; 최한곤[최한곤] |
2014-07 | Development of a novel triamcinolone acetonide-loaded spray solution for the treatment of stomatitis | 용철순; 김동육[김동육]; 김용일; 한홍희; Fakhar ud Din[Fakhar ud Din]; 조관형[조관형]; 김종오; 최한곤[최한곤] |
2015-04 | Development of a rebamipide solid dispersion system with improved dissolution and oral bioavailability | 김종오; 로샨프라단; 트란탄힙; 최주연; 최임순; 최한곤[최한곤]; 용철순 |
2010-07 | Development of an itraconazole-loaded gelatin microcapsule with enhanced oral bioavailability: physicochemical characterization and in-vivo evaluation | 최한곤; 용철순; 이동훈; 오동훈; 이정훈; 여우현; 박영준[박영준]; 조관형[조관형] |
2014-11 | Development of direct compression entecavir 0.5 mg-loaded tablet exhibiting enhanced content uniformity | 김종오; 아비드 유사프[아비드 유사프]; 지준필[지준필]; 황승림[황승림]; 맹한주[맹한주]; 박영준[박영준]; 최한곤[최한곤]; 조관형[조관형]; 용철순 |
2013-08 | Development of docetaxel-loaded solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced chemotherapeutic effect | 김종오; 서윤기; 김동욱[김동욱]; 최한곤[최한곤]; 티르거네쉬라마사미; 김정환; 마라시니니르말; 용철순; 김진기[김진기]; 오유경[오유경]; 김대환 |
2014-02 | Development of flurbiprofen-loaded nanoparticles with a narrow size distribution using sucrose | 용철순; 엄의동; 김동욱[김동욱]; 김종오; 최한곤[최한곤]; 오동훈 |
2012-11 | Development of ligustrazine-loaded lipid emulsion: Formulation optimization, characterization and biodistribution | 김종오; Lijun Wei[Lijun Wei]; 마라시니니르말; Gao Li[Gao Li]; 용철순; Qizhe Quan[Qizhe Quan] |
2014-04 | Development of novel fast-dissolving tacrolimus solid dispersion-loaded prolonged release tablet | 용철순; 조정현; 김용일; 김동욱[김동욱]; Abid M. Yousaf[Abid M. Yousaf]; 김종오; 우종수[우종수]; 최한곤[최한곤] |
2012-01 | Development of novel flurbiprofen-loaded solid self-microemulsifying drug delivery system using gelatin as solid carrier | 용철순; 김동욱[김동욱]; 강준혁[강준혁]; 오동훈[오동훈]; 최한곤[최한곤] |
2012-03 | Development of novel ibuprofen-loaded solid dispersion with enhanced bioavailability using cycloamylose | 용철순; 백형희[백형희]; 김대환[김대환]; 권소영[권소영]; 노신정[노신정]; 김동욱[김동욱]; 최한곤[최한곤]; 김용로[김용로] |
2010-08 | Development of Novel Itraconazole-loaded Solid Dispersion without Crystalline Change with Improved Bioavailability | 용철순; 최한곤; 박영준[박영준]; 현경희[현경희]; 오동훈[오동훈]; 프라바가[프라바가]; 양호준[양호준]; 여우현[여우현]; 이미경[이미경] |
2010-08 | Development of novel sibutramine base-loaded solid dispersion with gelatin and HPMC: Physicochemical characterization and pharmacokinetics in beagle dogs | 최한곤; 용철순; 황두형; 임현태; 김영란; 프라바; 오동훈; 조관형[조관형]; 이용복[이용복] |
2013-01 | Development of raloxifene-solid dispersion with improved oral bioavailability via spray-drying technique | 김종오; 트란탄힙; 포우델비자이; 마라시니니르말; 최한곤[최한곤]; 용철순; 우종수[우종수] |
2012-05 | Development of sildenafil-loaded orally disintegrating tablet with new lactate salt | 용철순; 정시영[정시영]; 김동욱[김동욱]; 서윤기[서윤기]; 우종수[우종수]; 최한곤[최한곤] |
2011-01 | Development of thermo-sensitive injectable hydrogel with sustained release of doxorubicin: Rheological characterization and in vivo evaluation in rats | 용철순; 현경희[현경희]; 엄의동[엄의동]; 오동훈[오동훈]; 최영근[최영근]; 최한곤[최한곤] |
2010-06 | Development of valsartan-loaded gelatin microcapsule without crystal change using hydroxypropylmethylcellulose as a stabilizer | 최한곤; 용철순; 이동훈; 오동훈; 양관열; 서윤기; 김종오; 김용일; 엄위동[엄위동] |
2014-08 | Development of Vorinostat-Loaded Solid Lipid Nanoparticles to Enhance Pharmacokinetics and Efficacy against Multidrug-Resistant Cancer Cells | 김종오; 트란탄힙; 티르거네쉬라마사미; 트롱두이히유; 신범수[신범수]; 최한곤[최한곤]; 용철순 |
2013-08 | Docetaxel-Loaded Polylactic Acid-Co-Glycolic Acid Nanoparticles: Formulation, Physicochemical Characterization and Cytotoxicity Studies | 김종오; 로샨프라단; 포우델비자이; 티르거네쉬라마사미; 최한곤[최한곤]; 용철순 |
2013-07 | Docetaxel-Loaded Thermosensitive and Bioadhesive Nanomicelles as a Rectal Drug Delivery System for Enhanced Chemotherapeutic Effect | 용철순; 서윤기; 김동욱[김동욱]; 여우현; 티르거네쉬라마사미; 오유경[오유경]; 박영준[박영준]; 김정애; 오동훈; 구세광[구세광]; 김진기[김진기]; 최한곤[최한곤]; 김종오 |
2013-12 | Docetaxel-loaded thermosensitive liquid suppository: optimization of rheological properties | 김종오; 여우현; 티르거네쉬라마사미; 김동욱[김동욱]; 조혁준; 김용일; 조관형; 용철순; 최한곤[최한곤] |
2011-04 | Effect of Charge Carrier Lipid on Skin Penetration, Retention, and Hair Growth of Topically Applied Finasteride-Containing Liposomes | 유봉규; 이상임[이상임]; 산토쉬 스리라만[산토쉬 스리라만]; 스리니바산 샨무감[스리니바산 샨무감]; 렌가라잔 바스카란[렌가라잔 바스카란]; 용철순; 윤상권[윤상권]; 최한곤[최한곤] |
2012-09 | Effect of dose and dosage interval on the oral bioavailability of docetaxel in combination with a curcumin self-emulsifying drug delivery system (SEDDS) | 용철순; 마라시니니르말; 최영근; 김종오; 우종수[우종수]; 최한곤[최한곤]; 엄의동 |
2011-01 | Effect of process parameters on nanoemulsion droplet size and distribution in SPG membrane emulsification | 용철순; 오동훈[오동훈]; 프라바가 [프라바가 ]; 오유경[오유경]; 김대덕[김대덕]; 최한곤[최한곤] |
2013-04 | Effect of saturated fatty acids on tacrolimus-loaded liquid crystalline nanoparticles | 용철순; 김종오; 라즈쿠마르타파; 렌가르잔; 티아가라쟌; 유정현; 유봉규[유봉규] |
2010-07 | Effect of sodium carboxymethylcellulose and fucidic acid on the gel characterization of polyvinylalcohol-based wound dressing | 최한곤; 용철순; 이정훈; 오동훈; 황두형; 박명관; 권기철; 임수정[임수정]; 이미경[이미경] |
2015-04 | Effect of the preparation method on crystallinity, particle size, aqueous solubility and dissolution of different samples of the poorly water-soluble fenofibrate with HP-beta-CD | 용철순; Abid Mehmood Yousaf[Abid Mehmood Yousaf]; 김동욱[김동욱]; 조관형[조관형]; 김종오; 최한곤[최한곤] |
2010-07 | Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus | 최한곤; 용철순; 조정현; 이원모; 오동훈; 서윤기; 박영준[박영준]; 조관형[조관형] |
2012-11 | Effects of Noscarna (TM) on hypertrophic scarring in the rabbit ear model: Histopathological aspects | 용철순; 김정환; 트란탄힙; 김보견[김보견]; 강민경[강민경]; 도의선[도의선]; 장선우[장선우]; 손미원[손미원]; 손영택[손영택]; 최한곤[최한곤]; 김종오; 구세광[구세광]; 조혁준; 전준호[전준호]; 한상덕[한상덕]; 이동원 |
2012-05 | Effects of Silicone-Based Gels Containing Allantoin, Dexpanthenol and Heparin on Hypertrophic Scarring in the Rabbit Ear Model | 김종오; 용철순; 김건국; 구세광[구세광]; 이동원; 마라시니[마라시니]; 로샨[로샨]; 손미원[손미원]; 전준호[전준호]; 장선우[장선우]; 진성규[진성규]; 강민경[강민경]; 최한곤[최한곤] |
2012-02 | Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS) | 용철순; 강준혁[강준혁]; 오동훈[오동훈]; 오유경[오유경]; 최한곤[최한곤] |
2015-04 | Engineering of a lipid-polymer nanoarchitectural platform for highly effective combination therapy of doxorubicin and irinotecan | 김종오; 티르거네쉬라마사미; 루딸라히마빈두; 최주연; 트란탄힙; 김정환; 구세광[구세광]; 최한곤[최한곤]; 용철순 |
2011-06 | Enhanced bioavailability and retinal accumulation of lutein from self-emulsifying phospholipid suspension (SEPS) | 용철순; 스리니바산 샨무간[스리니바산 샨무간]; 박재현[박재현]; 김경수[김경수]; 박종주[박종주]; 최한곤[최한곤]; 우종수[우종수] |
2010-10 | Enhanced Dissolution of Coenzyme Q10 using Solid Dispersions Prepared by Low Temperature Melting Method | 용철순; 강준혁[강준혁]; 엄위동[엄위동]; 김현찬[김현찬]; 이성능[이성능]; 최한곤[최한곤] |
2011-08 | Enhanced Oral Bioavailability of Curcumin via a Solid Lipid-Based Self-Emulsifying Drug Delivery System Using a Spray-Drying Technique | 용철순; 김정애; 곽미경; 유봉규; 최한곤[최한곤]; 엄의동[엄의동] |
2010-10 | Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin | 용철순; 최한곤[최한곤]; 엄의동[엄의동]; 김대환[김대환]; 성준호[성준호] |
2015-03 | Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation | 김종오; AM Yousaf[AM Yousaf]; 김동욱[김동욱]; 오유경[오유경]; 최한곤[최한곤]; 용철순 |
2010-02 | Enhanced Oral Bioavailability of Flurbiprofen by Combined Use of Micelle Solution and Inclusion Compound | 최한곤; 용철순; 이동훈; 한묘정; 프라바; 오동훈; 조정현; 서윤기; 박상만; 김종오; 엄위동[엄위동] |
2011-03 | Enhanced Solubility and Bioavailability of Flurbiprofen by Cycloamylose | 용철순; 백형희[백형희]; 권소영[권소영]; 노신정[노신정]; 이원석[이원석]; 양호준[양호준]; 하정미[하정미]; 최한곤[최한곤]; 김용로[김용로] |
2010-02 | Enhanced Solubility and Bioavailability of Sibutramine Base by Solid Dispersion System with Aqueous Medium | 최한곤; 용철순; 우종수; 이동훈; 장기영; 오동훈; 서윤기; 김영란; 김종오; 강원구[강원구]; 이만형[이만형]; 배경진[배경진]; 오유경[오유경]; 지준필[지준필]; 박영준[박영준] |
2012-09 | Enhanced solubility and oral bioavailability of itraconazole by combining membrane emulsification and spray drying technique | 용철순; 최영근[최영근]; 포델 비자이[포델 비자이]; 마라시니니르말[마라시니니르말]; 양관열[양관열]; 김정환[김정환]; 김종오; 최한곤[최한곤] |
2014-02 | Enhanced Topical Delivery of Finasteride Using Glyceryl Monooleate-Based Liquid Crystalline Nanoparticles Stabilized by Cremophor Surfactants | 용철순; 티아가라쟌; 렌가르잔; 유봉규[유봉규] |